论文部分内容阅读
目的探讨喘乐宁、爱喘乐、普米克联合沐舒坦氧驱动雾化吸入治疗毛细支气管炎的疗效。方法将毛细支气管炎患儿126例随机分为两组,观察组69例,对照组57例,两组常规治疗方法相同,观察组加予喘乐宁、爱喘乐、普米克联合沐舒坦氧驱动雾化吸入,对照组仅予常规治疗。观察两组治疗效果及解除主要症状和体征的时间。结果观察组治愈率、缓解喘憋及缩短哮鸣音持续时间均明显优于对照组(P<0.05)。结论喘乐宁、爱喘乐、普米克联合沐舒坦氧驱动雾化吸入治疗毛细支气管炎显效迅速,疗效显著。
Objective To investigate the curative effect of the treatment of bronchiolitis with inhalation of salbutamol, etrastoyl and promethazepam combined with mucosolvan. Methods 126 cases of children with bronchiolitis were randomly divided into two groups, 69 cases in the observation group and 57 cases in the control group. The two groups were given the same conventional treatment method. The observation group was treated with salbutamol, Driven aerosol inhalation, the control group only conventional treatment. The therapeutic effect and the time to relieve the main symptoms and signs of both groups were observed. Results The cure rate, alleviation of wheezing and shortening wheezing duration in the observation group were significantly better than those in the control group (P <0.05). Conclusion Astragalin, Atrazole, Purcek combined with Mucosidean aerosol inhalation treatment of bronchiolitis markedly effective, significant effect.